1 |
M. P. Diamond, E. L. Burns, "Seprafilm adhesion barrier (2)", Genecol. Surg., 9, 247 (2012)
DOI
ScienceOn
|
2 |
H. Lamoutte, R. Chatterji, "SurgiWrap(R), Mast bioresorbable sheet use for the prevention of soft tissue attachment; a two year experience", Biomaterials / Bioresorbable Technol., Mast Biosurgery (2005).
|
3 |
K. Sekiba, "Use of Interceed(TC7) absorbable adhesion barrier to reduce postoperative adhesion reformation in infertility and endometriosis surgery", Obstet. Gynecol., 79, 518 (1992).
|
4 |
J. N. Gutmann, M. P. Diamond, "Principles of laparoscopic microsurgery and adhesion prevention", New York, Springer, 55 (1992).
|
5 |
J. N. Gutmann, A. S Penzias, et al, "Adhesions in reproductive surgery", St. Louis, Mosby, 681 (1995).
|
6 |
Y. Liu, H. Li et al, "Crosslinked hyaluronan hydrogels containing mitomycin C reduce postoperative abdominal adhesions", Fertil. Steril., 83, 1275 (2005).
DOI
ScienceOn
|
7 |
Y. Yeo, D. S. Kohane, "Polymer in the prevention of peritoneal adhesions", Eur. J. Pharm. Biopharm., 68, 57 (2008).
DOI
ScienceOn
|
8 |
R. M. Kamel, "Prevention of postoperative peritoneal adhesions", Eur. J. Obstet. & Gynecol. and Rep. Biol., 150, 111 (2010).
DOI
ScienceOn
|
9 |
J. H. Lee, H. Y. Kim et al, "Recent R&D Trends of Medical Adhesives and Anti-adhesion Membranes", Biomaterials Research, 14, 66 (2010).
|
10 |
G. S. di Zerega, S. J. Verco, et al, "A randomized, controlled pilot study of the safety and efficacy of 4% icodextrin solution in the reduction adhesions following laparoscopic gynaecological surgery", Hum. Reprod., 17, 1031 (2002).
DOI
ScienceOn
|
11 |
K. Hosie, J. A. Gilbert, et al, "Fluid dynamics in man of an intraperitoneal drug delivery solution: 4% icodextrin", Drug Delivery, 8, 9 (2001).
DOI
|
12 |
D. Menzies, M. H. Pascual, "Use of icodextrin 4% solution in the prevention of adhesion formation following general surgery: from the multicentre ARIEL Registry", Ann. R. Coll. Surg. Engl., 88, 375 (2006).
DOI
ScienceOn
|
13 |
G. S. di Zerega, "Use of adhesion prevention barriers in pelvic reconstructive and gynecologic surgery", New York: Springer-Verlag, 379 (2000).
|
14 |
C. K. Sites, B. A. Jensen, et al, "Transvaginal ultrasonographic assessment of Hyskon or lactated Ringer's solution instillation after laparoscopy: Randomized, controlled study", J. Ultrasound Med., 16, 195 (1997).
|
15 |
M. Diamond, "Reduction of de novo postsurgical adhesions by intraoperative precoating with Sepracoat (HAL-C) solution: a prospective, randomized, blinded, placebo-controlled multicenter study", Fertil. Steril., 69, 1067 (1998).
DOI
ScienceOn
|
16 |
A. Watson, P Vandekerckhove, et al, "Liquid and fluid agents for preventing adhesions after surgery for subfertility", Cochrane Database Syst. Rev., (2000).
|
17 |
T. Kucukozkan, B. Ersoy, et al, "Prevention of adhesions by sodium chromoglycate, dexamethasone, saline and aprotinin after pelvic surgery", ANZ J. Surg., 74, 1111 (2004).
DOI
ScienceOn
|
18 |
C. C Buckenmaier, A.E Pusateri, et al, "Comparison of antiadhesive treatments using an objective rat model", Am. Surg., 65, 274 (1999).
|
19 |
Practice Committee of the American Society for Reproductive Medicine, "Pathogenesis, consequences, and control of peritoneal adhesions in gynecologic surgery", Fertil. Steril., 88, 21 (2007).
DOI
ScienceOn
|
20 |
J Kutlay, Y Ozer, et al, "Comparative effectiveness of several agents for preventing postoperative adhesions", World J. Surg., 28, 662 (2004).
DOI
ScienceOn
|
21 |
R. P. Jansen, "Failure of peritoneal irrigation with heparin during pelvic operations upon young women to reduce adhesions", Surg. Gynecol. Obstet., 166, 154 (1988).
|
22 |
S. M. Chowdhury and J. A Hubbell, "Adhesion prevention with ancrod release via a tissue-adherent hydrogel", J. Surg. Res., 61, 58 (1996).
DOI
ScienceOn
|
23 |
L. Holmdahl, "The role of fibrinolysis in adhesion formation", Eur. J. Surg. Suppl., 577, 24 (1997).
|
24 |
G. S. di Zerega, "Gontemporary adhesion prevention", Fertil. Steril., 61, 219 (1994).
|
25 |
K. E. Rodgers, G. S di Zerega, "Developing pharmacologic agents for adhesion prevention", Springer-Verlag, New York, 441 (2000).
|
26 |
J. L. Hill-West, R.C. Dunn, et al, "Local release of fibrinolytic agents for adhesion prevention", J. Surg. Res., 59, 759 (1995).
DOI
ScienceOn
|
27 |
L. E. Holmdahl, M. Al-Jabreen, et al, "Role of fibrinolysis in the formation of postoperative adhesions", Wound Rep. Reg., 2, 171 (1994).
DOI
ScienceOn
|
28 |
D. Menzies, H. Ellis, "The role of plasminogen activator in adhesion prevention", Surg., Gynecol. & Obstet., 172, 362 (1991).
|
29 |
W. Arung, M. Meurisse, et al, "Pathophysiology and prevention of postoperative peritoneal adhesions", World J. Gastro., 17, 4545 (2011).
DOI
ScienceOn
|
30 |
B. W. J. Hellebrekers and T. Kooistra, "Pathogenesis of postoperative adhesion formation", Br. J. Surg., 98, 1503 (2011).
DOI
ScienceOn
|
31 |
A. Imai, H. Takagi et al, "Non-barrier agents for postoperative adhesion prevention : clinical and preclinical aspects", Arch Gynecol. Obstet., 282, 269 (2010).
DOI
|
32 |
K. Falk, P. Bjorquist, M. Stromquist, "Reduction of experimental adhesion formation by inhibition of plasminogen activator inhibitor type", Br. J. Surg., 99, 286 (2001).
|
33 |
Y. Yeo, E. Bellas, "Peritoneal adhesion prevention with an in situ cross-linkable hyaluronan gel containing tissue-type plasminogen activator in a rabbit model", Biomaterials, 28, 3704 (2007).
DOI
ScienceOn
|
34 |
K. E. Rodgers, W. Girgis, R. Lilford, "Reduction of adhesion formation by intraperitoneal administration of anti-inflammatory peptide 2", J. Invest Surg., 10, 31 (1997).
DOI
|
35 |
INTERCEED(TC7) Adhesion Barrier Study Group, "Prevention of postsurgical adhesions by INTERCEED(TC7), an absorbable adhesion barrier: a prospective randomized multicenter clinical study", Fertil. Steril., 51, 933 (1989).
|
36 |
G. M. Boland, R. J. Weigel, "Formation and prevention of postoperative abdominal adhesions", J. Surg. Res., 132, 3 (2006).
DOI
ScienceOn
|
37 |
K. Pagidas, T. Tulandi, "Effects of Ringer's lactate, interceed(TC7) and Gore-Tex surgical membrane on postsurgical adhesion formation", Fertil. Steril., 57, 199 (1992).
|
38 |
R. L. Reid, P. M. Hahn, et al, "A randomised clinical trial of oxidized regenerated cellulose adhesion barrier (Interceed, TC7) alone or in combination with heparin," Fertil. Steril., 67, 23 (1997).
DOI
ScienceOn
|
39 |
C. M. March, S. Boyers, et al, "Prevention of adhesion formation/reformation with the Gore-Tex surgical membrane", Prog. Clin. Biol. Res., 381, 253 (1993).
|
40 |
이영우, 추보영, et al, "가토 모델에서 복강경 수술 시 전기방사 나노섬유 유착방지제의 효과 및 안전성", 대한외과학회지, 76, 73 (2009).
|
41 |
A. Johns, "Evidence-based prevention of postoperative adhesions", Hum. Reprod. Update, 7, 577 (2001).
DOI
ScienceOn
|
42 |
D. Al-Jaroudi, T. Tulandi, Adhesion prevention in gynecologic surgery, Obstet. Gynecol. Surg., 59, 360 (2004).
DOI
ScienceOn
|
43 |
J. W Burns, K, Skinner, et al, "Prevention of tissue injury and postsurgical adhesions by precoating tissues with hyaluronic acid solutions", J. Surg. Res., 59, 644 (1995).
DOI
ScienceOn
|
44 |
M. Korrel, "Endometriosis: a common cause of pelvic pain", Adhes. News Views, 5, 18 (2004).
|
45 |
R. Ferland, D. Mulani, et al, "Evaluation of a sprayable polyethylene glycol adhesion barrier in a porcine efficacy model", Hum. Reprod., 16, 2718 (2001).
DOI
ScienceOn
|
46 |
www.biorane.com
|
47 |
M. Diamond, "Reduction of adhesions after uterine myomectomy by Seprafilm membrane (HAL-F): a blinded, prospective, randomized, multicenter clinical study, Seprafilm Adhesion Study Group", Fertil. Steril., 66, 904 (1996).
|
48 |
W. Vrijland, L. Tseng, et al, "Fewer intraperitoneal adhesions with use of hyaluronic acid-carboxymethylcellulose membrane: a randomized clinical trial", Ann. Surg., 235, 193 (2002).
DOI
ScienceOn
|
49 |
C. Kinsky and T. Cunningham, U. S. Patent, 4,840,626 (1989).
|
50 |
www.mastbio.com
|
51 |
Frost and Sullivan, U.S. markets for hemostats-tissue sealant-tissue adhesive and adhesion prevention products in December. 2004
|
52 |
M. P. Diamond, E. L. Burns, "Seprafilm adhesion barrier (1)", Genecol. Surg., 9, 237 (2012)
DOI
ScienceOn
|